, Russian Federation
UDK 61 Медицина. Охрана здоровья
A case of secondary amyloidosis in rheumatoid arthritis in a 28-year-old girl who did not receive sufficient basic therapy due to low adherence to treatment is presented. During the course of the disease, proteinuria developed, widespread edema, digestive disorders. The development of symptoms over time, the process of diagnosis, the selection of therapy, rehabilitation are demonstrated.
secondary amyloidosis, rheumatoid arthritis, proteinuria, leflunomide, olokizumab
1. Rossiyskie klinicheskie rekomendacii. Revmatologiya / pod red. E.L. Nasonova. – M.: GEOTAR-Media, 2017. – 464 s. 17-58
2. REVMATOIDNYY ARTRIT. Uchebno-metodicheskoe posobie. – Maykop: izd-vo MGTU, 2014. – 120 s. 67-71
3. Romanova I.A., Magdeeva N.A., Nikitina N.M. Sluchay bystrogo progressirovaniya amiloidoza pochek pri revmatoidnom artrite. Saratovskiy nauchno-medicinskiy zhurnal 2017; 13 (4): 821–823 s.
4. Rameev V.V., Moiseev S.V., Kozlovskaya L.V. AA-amiloidoz pri autovospalitel'nyh zabolevaniyah. Klin. farmakol. ter 2021;30(4): 52-61 s.
5. Tushina, A.K. Diagnostika nasledstvennoy predraspolozhennosti k razvitiyu amiloidoza u pacientov s revmatoidnym artritom: instrukciya po primeneniyu / A.K. Tushina [i dr.]. – Minsk, 2011. – 16 s
6. Diagnostika i lechenie otdel'nyh form revmaticheskih zabolevaniy s pozicii dokazatel'noy mediciny. – Uchebnometodicheskoe posobie. – S.K.Adzhigaytkanova. – M., GBOU VPO RNIMU im. N.I.Pirogova, 2013. – 52 s. 13-14 c.
7. Klinicheskie rekomendacii po diagnostike i lecheniyu sistemnogo amiloidoza - L.V. Lysenko (Kozlovskaya), V.V. Rameev, S.V. Moiseev, O.V. Blagova, E.I. Bogdanov, G.E. Gendlin, D.A. Grishina, A.Ya. Gudkova, E.V. Zaharova, O.E. Zinov'eva, O.M. Moiseeva, S.S. Nikitin, V.A. Parfenov, N.A. Suponeva, S.N. Tereschenko, 2020. – 12 s. 10 s.
8. Vnutrennie bolezni / Pod red. A.I. Martynova, N.A. Muhina, V.S. Moiseeva. – T. 1. – M.: GEOTAR/Med, 2004. – S.524/530.
9. Nefrologiya / Pod red. E.M. Shilova. – M.: GEOTAR/ Media, 2007. – S.347/348.
10. M.V. Sklyanova, A.N. Kalyagin, G.I. Scherbakov, I.A. Zimina – Amiloidoz v praktie vracha-revmatologa. Sibirskiy medicinskiy zhurnal, 2009g, №3 – 150-152 s.
11. A.N. Shishkin, D.E. Yanchenko – Amiloidoz. Zhuranal Nefrologiya, 1998g – 30-42
12. V.V. Rameev, L.V. Kozlovskaya, I.A. Sarkisova – Amiloidoz: voprosy diagnostiki i lecheniya. Klinicist, 2006g, №4 -35-39
13. V.V. Rameev - Sistemnyy amiloidoz na sovremennom etape: rol' porazheniya pochek v progressirovanii zabolevaniya, puti optimizacii diagnostiki i uluchsheniya prognoza. Dissertaciya, 2020g, 228 s.
14. M.Sh. Nasyrova – Sovremennoe sostoyanie i aktual'nye voprosy revmatoidnogo artrita. Medicinskiy vestnik Nacional'noy akademii nauk Tadzhikistana, 2009 g. 424-426 s.
15. Aleksandrova E.H., Nasonov E.L. Immunopatologiya revmatoidnogo artrita; pod red. E.L. Nasonova.- M.:IMA-PRESS, 2013. – 549 s.
16. E.L. Nasonov. Lechenie revmatoidnogo artrita – Klinicheskaya farmakologiya i terapiya, 2017 g, 4-11 s.
17. Nasonov E.L., Karateev D.E., Chichasova N.V. Novye rekomendacii po lecheniyu revmatoidnogo artrita: mesto metotreksata. Nauchno-prakticheskaya revmatologiya 2014. - 52s, 8 – 26s.
18. Nasonov EL, Lila AM. Effektivnost' i bezopasnost' sarilumaba (polnost'yu chelovecheskie monoklonal'nye antitela k receptoru interleykina-6) pri revmatoidnom artrite: novye dannye. Nauchno-prakticheskaya revmatologiya. 2019; 57(5) :564–577
19. Lisicyna TA, Vel'tischev DYu, Lila AM, Nasonov EL. Interleykin-6 kak patogeneticheskiy faktor, oposreduyuschiy formirovanie klinicheskih proyavleniy, i mishen' dlya terapii revmaticheskih zabolevaniy i depressivnyh rasstroystv. Nauchno-prakticheskaya revmatologiya. 2019;57(3):318–327.
20. E.L. Nasonov, T.A Lisicyna, E.V. Zonova, S.M. Kuz'kina. Vliyanie olokizumaba na ishody, ocenivaemye pacientom s revmatoidnym artritom: rezul'taty dvoynogo slepogo randomizirovannogo placebokontroliruemogo mnogocentrovogo issledovaniya III fazy (CREDO 1). - Nauchno-prakticheskaya revmatologiya, 2021g, 62–69s.
